Presented by:
Amy Zarzeczny, Associate Professor, JSGS
This presentation will share results from a case study analysis of previous regulation and governance of access to unproven medical interventions provided by physicians in Canada. The cases included chelation therapy for applications other than treating heavy metal toxicity, liberation therapy for multiple sclerosis, and unproven stem cell interventions. The data collection and analysis focused primarily on regulatory and governance tools and strategies that are empowered or constrained by law. One of the primary goals of this research was to identify lessons that could be used to inform and strengthen future regulatory and governance strategies and policy development regarding access to unproven medical interventions in Canada.
About the speaker:
Amy Zarzeczny is an Associate Professor with the University of Regina campus of the Johnson Shoyama Graduate School of Public Policy and currently serves as the Program Director for its Master of Health Administration program. Zarzeczny is also a member of the Editorial Board for the Health Reform Observer journal, a member of the board for the Justice Emmett Hall Memorial Foundation, an External Research Fellow with the University of Alberta's Health Law Institute, and a Pro Bono member of the Law Society of Saskatchewan. Her research focuses on health law and health policy issues, with a focus on regulation and governance of biotechnology and clinical innovation. Her research has been funded by the Canadian Institutes of Health Research, the Saskatchewan Health Research Foundation, and the Stem Cell Network.
Event Details
- When:
- Time:
- 11:30 AM - 12:30 PM CST
- Location:
- Join us on Zoom! Please register by clicking the link below and the connection details will be sent by email.
- File:
- Event Communique